Clinical Trial

CO2 Modulation in Endovascular Thrombectomy for Acute Ischemic Stroke

Study acronym: COMET-AIS
Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated October 6, 2025 (before its estimated July 19, 2026 completion). Its status may not reflect the trial's current state.
Summary
Acute ischemic stroke due to large vessel occlusion is responsible of cerebral blood flow impairment with a progressive and extensive ischemic process. Cerebral collateral circulation may preserve an ischemic penumbra that could recover providing timely reperfusion of the occluded vessel. Mechanical thrombectomy is the standard of care for anterior circulation large vessel reperfusion. Strategy to promote cerebral blood flow in collateral circulation before reperfusion is scarce and rely mainly on blood pressure maintenance. Carbon dioxide is a potent cerebral vasodilator that could enhance collateral circulation blood flow and cerebral protection before reperfusion. General anesthesia with endotracheal mechanical ventilation could be used for thrombectomy and give the opportunity to modulate and control carbon dioxide tension in the blood. This study will test the effect of moderate hypercapnia on penumbral collateral circulation before reperfusion during mechanical thrombectomy for anterior circulation acute ischemic stroke under general anesthesia.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-09-10; most recent amendment 2025-09-30.
Status change: Not Yet Recruiting → Recruiting 2022-12-21
Trial Details
NCT Number NCT05051397
Lead Sponsor University Hospital, Clermont-Ferrand
Conditions Ischemic Stroke, Acute, Thrombectomy, Anesthesia, General, Cerebrovascular Circulation, Carbon Dioxide
Enrollment 50 participants
Start Date 2022-07-20
Primary Completion 2026-07-19 (estimated)
Study Completion 2026-10-19 (estimated)
Updated on ClinicalTrials.gov 2025-10-06